HCA Healthcare (HCA)
(Delayed Data from NYSE)
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$415.54 USD
+9.06 (2.23%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $415.66 +0.12 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Zacks News
Watch These 5 Stocks That Recently Hiked Their Dividends
by Nalak Das
Dividend-paying stocks should be in demand as investors will try to safeguard their portfolios. Five such stocks are: HCA, BAH, GATX, NXPI and MSCI.
HCA Healthcare (HCA) Q4 Earnings Lag on High Costs, Hikes Dividend
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results suffer a blow from added expenses incurred due to Hurricane Ian. Increased patient admissions partly offset the downside.
Here's How Much You'd Have If You Invested $1000 in HCA Healthcare a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
HCA Healthcare (HCA) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -3.13% and 0.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why HCA (HCA) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
HCA Healthcare (HCA) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter results are likely to reflect increased equivalent admissions and outpatient surgery cases.
Stocks Stage Rally Despite Growing Recession Indicators
by Mayur Thaker
All eyes on Q4 '22 earnings over the next two weeks.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Acadia Healthcare and Tenet Healthcare are part of the Zacks Industry Outlook article.
Investors Should Watch These 4 Hospital Stocks Despite Headwinds
by Kaibalya Pravo Dey
Rising costs amid inflationary pressures are trimming margins for the Zacks Medical-Hospital industry players. Yet, HCA Healthcare (HCA), Universal Health (UHS), Acadia Healthcare (ACHC) and Tenet Healthcare (THC) are poised to win big with improving volumes.
HCA Healthcare (HCA) Rises 43% in 6 Months: More Room to Run?
by Zacks Equity Research
HCA Healthcare (HCA) is well-poised for growth due to growing patient volumes, acquisitions and adequate cash-generating abilities.
HCA Healthcare (HCA) Unit in Talks to Buy Wise Health System
by Zacks Equity Research
HCA Healthcare's (HCA) deal with Wise Health System is expected to boost its footprint and market share in Texas.
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
HCA Healthcare's (HCA) ESR Program Aids Post-Surgery Recovery
by Zacks Equity Research
HCA Healthcare's (HCA) ESR program remains on track to attract more patients to choose HCA's healthcare facilities for undergoing surgeries.
Why Is Community Health Systems (CYH) Up 16.9% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Universal Health Services (UHS) Up 18.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Add McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Pediatrix (MD) Down 19% Since Q3 Earnings & Revenue Miss
by Zacks Equity Research
Pediatrix's (MD) Q3 results reflect volume constraints and an elevated expense level. Adjusted EBITDA is now expected within $240-$245 million, down from the earlier view of $260-$270 million.
Ensign Group (ENSG) Shares Up 2% Despite Q3 Earnings Miss
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter results reflect strength in the Skilled Services segment. A hiked 2022 EPS guidance remains noteworthy. However, escalated expenses are bothersome.
Cigna (CI) Q3 Earnings Top on Evernorth Unit, 2022 EPS View Up
by Zacks Equity Research
Cigna's (CI) third-quarter results reflect strong pharmacy revenues coupled with solid segmental performances. A hiked 2022 EPS outlook is commendable.
Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit
by Zacks Equity Research
Humana's (HUM) third-quarter earnings gain from solid premiums and membership growth within its individual Medicare Advantage business coupled with a well-performing Healthcare Services segment.
Molina Healthcare (MOH) Q3 Earnings Top, 2022 EPS View Up
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect an expanding customer base within its Medicare and Medicaid businesses. Management hikes 2022 adjusted EPS guidance to a minimum of $17.75.
Universal Health (UHS) Q3 Earnings Top on Better Patient Volumes
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect growing patient admissions at its segments. However, margins are hurt by escalated labor costs.
Centene (CNC) Q3 Earnings Top on Medicaid Arm, Revenues Rise Y/Y
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect solid membership growth within its Medicaid and Medicare businesses. Management currently expects adjusted EPS within $5.65-$5.75 for 2022.
4 Stocks Navigating Through Hospital Industry Headwinds (Revised)
by Kaibalya Pravo Dey
Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.
Company News for Oct 24, 2022
by Zacks Equity Research
Companies in The News Are: AXP, SLB, DIS, HCA